Amarin Corporation PLC Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending September 30, 2022 was -29.39% (a -187.16% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -29.16%
  • Annual Research and Development (R&D) Expenses Growth for 2021 was -28.92% (a -375.43% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was 10.5% (a -126.97% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2019 was -38.93% (a -323.22% decrease from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending September 30, 2022 was -11.54% (a -16.13% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -60.0% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
-11.54% -13.76% -27.58% -28.85%
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Amarin Corporation PLC

Most recent Research and Development (R&D) Expenses Growthof AMRN including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Amarin Corporation PLC

Amarin Corporation PLC Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -29.39% 33.72% -1.7%
2021 -41.49% -31.32% -36.23% -8.77% -28.92%
2020 -23.33% 14.36% 39.82% 41.92% 10.5%
2019 -6.8% -36.59% -60.74% -38.43% -38.93%
2018 -0.33% 31.59% 32.61% 8.68% 17.44%
2017 17.39% -20.73% 8.87% -21.17% -6.06%
2016 -23.75% 3.04% 4.74% 8.85% -2.13%
2015 7.33% -9.44% 2.4% 7.75% 1.46%
2014 -25.1% -14.05% -32.95% -46.39% -30.82%
2013 -13.63% -19.57% 24.34% 359.17% 23.4%
2012 222.99% 247.8% 171.07% 6.9% 172.92%
2011 -20.12% -22.89%

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology